Navigation Links
Dilon Technologies Signs Amerinet for Breast-Specific Gamma Imaging
Date:7/16/2008

NEWPORT NEWS, Va., July 16 /PRNewswire/ -- Dilon Technologies, makers of a gamma imaging system optimized for early breast cancer detection, today announced a three-year agreement with Amerinet, a leading national group purchasing organization. Effective immediately, the relationship offers Amerinet's 26,000 acute and non-acute healthcare providers and their patients' access to the Dilon 6800 Gamma Camera, used in detecting and diagnosing very early stage breast cancers.

"Dilon Technologies is committed to enhancing the standard of healthcare in communities across the nation, said David Rom, National Accounts Director for Dilon. "This strategic partnership with Amerinet will help physicians with difficult-to-diagnose patients and continue to aid in the fight against breast cancer."

The Dilon 6800 performs a molecular breast imaging technique called Breast-Specific Gamma Imaging (BSGI), which can detect lesions independent of tissue density and discover very early stage cancers. BSGI serves as a complementary diagnostic adjunct procedure to mammography and ultrasound for difficult-to-diagnose patients. With BSGI, the patient receives a radioactive tracing agent that is absorbed by all the cells in the body. Cancerous cells in the breast, due to their increased rate of metabolic activity, absorb a greater amount of the tracing agent than normal healthy cells, and generally appear as "hot spots" on the BSGI image.

Amerinet strategically partners with healthcare providers to reduce costs and improve the delivery of quality care. Supported by a team of clinical, data and supply chain experts, Amerinet offers a suite of tools, programs and services including a comprehensive and competitive portfolio that delivers practical solutions to address members' specific needs. To learn more, visit http://www.amerinet-gpo.com.

About Dilon Technologies

Dilon Technologies is bringing innovative new medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform Breast-Specific Gamma Imaging (BSGI), a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; and The Rose, Houston. For more information on Dilon Technologies please visit http://www.dilon.com.


'/>"/>
SOURCE Dilon Technologies
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dilon Technologies Announces National Agreement with MedAssets
2. Settlement Reached Between Dilon Technologies and Naviscan on Patent Rights
3. Dilon Technologies Appoints New VP of Sales & Business Development
4. Dilon Technologies Explores Improvements in Molecular Breast Imaging
5. Wound Management Technologies, Inc. Announces Filing of a 510K
6. Alta Bates Medical Group (ABMG) Teams With Illumisys, LLC to Promote Quality of Care to Patients and Increase Adoption and Use of Health Information Technologies.
7. Althea Technologies Appoints E.J. Brandreth to Vice President of Quality and Regulatory
8. Netsmart Technologies Web Seminar Helps Behavioral Health Organizations Understand Electronic Prescribing And The Importance Of New Medicare-Related E-Prescribing Legislation
9. VNUS Medical Technologies to Report Second-Quarter 2008 Results and Webcast Teleconference on July 29
10. Cadient Groups GEL Interactive Technologies Celebrates Major Milestones for Immerse Exhibit Platform: 500th Exhibit Implementation and 250,000th Healthcare Professional Registered with Immerse Exhibit Platform
11. VNUS Medical Technologies, Inc. Announces Board of Director Resignation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and elimination ... safety and minimize the cost of development. In this webinar, sponsored by Molecular ... lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , In ...
(Date:4/28/2017)... ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in ... responds to and which He does not. Yisrayl says with so many titles and ... true name, but he says with a little Scripture, backed with a lot of research, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec Solutions announced the ... implement a Microsoft Dynamics GP solution that integrates to their PointClickCare EHR software ... in long-term care, Brooke Grove now has the capability to achieve its goal ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Rob Lowe is ... now he has leant his presence to an educational purpose as the host of ... important one being cancer. In a recent episode, the series focuses on thyroid cancer. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Manufacturing Services Market Analysis By Service (Manufacturing, Research), By Country, ... - 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing ... 2025 Low drug registration cost in Latin American ...
(Date:4/19/2017)... 19, 2017 The Mobile X-Ray product segment is ... CAGR during the forecast period Mobile X-Ray segment ... digital mobile X-Ray devices market, which is estimated to be ... at a CAGR of 7% over the forecast period. Mobile ... more than US$ 100 Mn in 2017 over 2016. The ...
(Date:4/19/2017)... YORK , April 19, 2017 ... This report on the prostate cancer therapeutics ... the global market. Increasing prevalence of prostate cancer, ... innovation in the development of new drugs & ... prostate cancer drug due to lesser side effects ...
Breaking Medicine Technology: